MapLight Therapeutics Inc
NASDAQ:MPLT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MapLight Therapeutics Inc
NASDAQ:MPLT
|
US |
Balance Sheet
Balance Sheet Decomposition
MapLight Therapeutics Inc
MapLight Therapeutics Inc
Balance Sheet
MapLight Therapeutics Inc
| Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
28
|
80
|
38
|
|
| Cash Equivalents |
28
|
80
|
38
|
|
| Short-Term Investments |
0
|
0
|
71
|
|
| Other Current Assets |
4
|
4
|
6
|
|
| Total Current Assets |
32
|
84
|
115
|
|
| PP&E Net |
7
|
7
|
8
|
|
| PP&E Gross |
7
|
7
|
8
|
|
| Accumulated Depreciation |
1
|
2
|
2
|
|
| Long-Term Investments |
0
|
0
|
11
|
|
| Other Long-Term Assets |
0
|
1
|
3
|
|
| Total Assets |
39
N/A
|
91
+132%
|
137
+50%
|
|
| Liabilities | ||||
| Accounts Payable |
4
|
3
|
2
|
|
| Accrued Liabilities |
0
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Other Current Liabilities |
9
|
11
|
13
|
|
| Total Current Liabilities |
13
|
15
|
16
|
|
| Long-Term Debt |
0
|
0
|
0
|
|
| Other Liabilities |
6
|
5
|
6
|
|
| Total Liabilities |
19
N/A
|
20
+9%
|
22
+8%
|
|
| Equity | ||||
| Common Stock |
84
|
189
|
309
|
|
| Retained Earnings |
66
|
122
|
199
|
|
| Additional Paid In Capital |
3
|
4
|
6
|
|
| Total Equity |
21
N/A
|
71
+242%
|
115
+62%
|
|
| Total Liabilities & Equity |
39
N/A
|
91
+132%
|
137
+50%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
41
|
41
|
41
|
|